Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (NY: THNR )

23.27 +0.46 (+2.02%)

Streaming Delayed Price Updated: 10:15 AM EST, Feb 5, 2025 Add to My Watchlist

Price and Volume

Volume	110
Open	23.27
Bid (Size)	23.22 (14)
Ask (Size)	23.34 (11)
Prev. Close	22.81
Today's Range	23.27 - 23.27
52wk Range	22.00 - 28.19
Shares Outstanding	1,800
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares

December 13, 2024

Recently, the company announced a massive $15 billion share buyback plan and a 15% dividend increase.

Via Benzinga

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'

July 18, 2024

Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry.

Via Benzinga

Performance

YTD	+2.84%	+2.84%
1 Month	+3.10%	+3.10%
3 Month	-7.61%	-7.61%
6 Month	-9.39%	-9.39%
1 Year	-8.38%	-8.38%

More News

ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential

June 07, 2024

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.